Browsing by Subject "Lipoteichoic acid"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Ftsh Sensitizes Methicillin-Resistant Staphylococcus aureus to -Lactam Antibiotics by Degrading YpfP, a Lipoteichoic Acid Synthesis Enzyme
    (MDPI, 2021-10-01) Yeo, Won-Sik; Jeong, Bohyun; Ullah, Nimat; Shah, Majid Ali; Ali, Amjad; Kim, Kyeong Kyu; Bae, Taeok; Microbiology and Immunology, School of Medicine
    In the Gram-positive pathogen Staphylococcus aureus, FtsH, a membrane-bound metalloprotease, plays a critical role in bacterial virulence and stress resistance. This protease is also known to sensitize methicillin-resistant Staphylococcus aureus (MRSA) to β-lactam antibiotics; however, the molecular mechanism is not known. Here, by the analysis of FtsH substrate mutants, we found that FtsH sensitizes MRSA specifically to β-lactams by degrading YpfP, the enzyme synthesizing the anchor molecule for lipoteichoic acid (LTA). Both the overexpression of FtsH and the disruption of ypfP-sensitized MRSA to β-lactams were observed. The knockout mutation in ftsH and ypfP increased the thickness of the cell wall. The β-lactam sensitization coincided with the production of aberrantly large LTA molecules. The combination of three mutations in the rpoC, vraB, and SAUSA300_2133 genes blocked the β-lactam-sensitizing effect of FtsH. Murine infection with the ypfP mutant could be treated by oxacillin, a β-lactam antibiotic ineffective against MRSA; however, the effective concentration of oxacillin differed depending on the S. aureus strain. Our study demonstrated that the β-lactam sensitizing effect of FtsH is due to its digestion of YpfP. It also suggests that the larger LTA molecules are responsible for the β-lactam sensitization phenotype, and YpfP is a viable target for developing novel anti-MRSA drugs.